- This strategic addition expands ERBC Group's non-clinical derisking capabilities to include efficacy, biodistribution, mechanistic and proof of concept studies based on in vitro and in vivo models…

ETISENSE (Lyon) and the EUROPEAN RESEARCH BIOLOGY CENTER (ERBC Group) announce a collaboration to develop and validate the DECRO telemetry solution for marmosets, a new world primate with several…

This strategic acquisition expands ERBC Group’s non-clinical research and development testing portfolio, adding in ovo models for anticancer drug development. Baugy, France, January 18th 2023 –…

UI Investissement, alongside MACSF, is supporting the development of ERBC Group, specialized in non-clinical research performing the evaluation of drug candidates for pharmaceutical and biotechnology…

ERBC (European Research Biology Center) and our partners Oncodesign, CYNBIOSE and PharmaLex a.r.c., presented a Digital Workshop “How do we keep you in the race of COVID19 ?“ during BioFIT 2020. Did…

ERBC, Oncodesign, Cynbiose, Aepodia and PharmaLex a.r.c. and Belgium are pleased to announce the signature of a partnering agreement to provide the biotech and pharma industry with a full-service…